USPTO serial 78731402
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
St-Laurent , Quebec, CA
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Terrence J. McAllister
TERRENCE J MCALLISTER OHLANDT, GREELEY, RUGGIERO & PERLE LLPONE LANDMARK SQ 10TH FLSTAMFORD, CT 06901-2682UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Schizophrenia, learning disorders, Bipolar Disorder, Depression, Alzheimer's Disease, Epilepsy, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Stroke, Addiction, Cerebral Ischemia, Neuropathy, Retinal Pigment Degeneneration, Glaucoma, Cardiac Arrhythmia, Shingles, Huntington's Chorea, Parkinson's Disease and anxiety disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases of the musculoskeletal and connective tissue system, Respiratory system, Circulatory system, Gastrointestinal system, Genitourinary system and Nervous system; Pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal and connective tissue system, namely, Arthritis, Psoriasis, Myocitis, Dermatitis, bone cancer and eczema; Pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system, namely, Asthma, Bronchitis, Sinusitis, Pharyngitis, Laryngitis, Tracheitis, rhinitis, Cystic fibrosis, Respiratory Infection, Acute respiratory Distress syndrome and emphysema; Pharmaceutical preparations for the treatment of diseases and disorders of the circulatory system, namely, Vasculitis, Haematuria syndrome, Artherosclerosis, Arteritis, Phlebitis, Carditis, Coronary Heart Disease, Ischemic Heart Disease, Angina and Acute Myocardial Infarction; Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders, namely, Irritable Bowel Syndrome, Ulcerative colitis, Crohn's Disease, Diverticulitis, Viral and Bacterial Infection, Peptic ulcer, Chronic hepatitis, Gingivitis, Periodentitis, Stomatitis, Gastritis, Gastrointestinal reflux disease and GI cancers; Pharmaceutical preparations for the treatment of the genitourinary diseases and disorders, namely, Cystitis, Polycystic kidney disease, Nephritic syndrome, Urinary Tract infection, Kidney Stones, Cystinosis, Prostatitis, Salpingitis, Endometriosis and GU cancers; Pharmaceutical preparations for the treatment of diseases and disorders of the nervous system, namely, Neuralgia, Neuropathy, Chronic cephalic pain, headache, migraine, psychogenic pain and spinal cord injury | ACTIVE | — |
| 042 | Pharmaceutical research and development, product evaluation and drug development | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 10, 2011 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 10, 2011 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 15, 2010 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jul 15, 2010 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jul 15, 2010 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 30, 2010 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 30, 2009 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 17, 2009 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 17, 2009 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 15, 2009 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 12, 2008 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 12, 2008 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 12, 2008 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 13, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 13, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2008 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 17, 2008 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 17, 2008 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 17, 2008 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 28, 2008 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 26, 2007 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 26, 2007 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 26, 2007 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 31, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2007 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 10, 2007 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 10, 2007 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 26, 2007 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 26, 2007 | ALIE | ASSIGNED TO LIE | — |
| Nov 21, 2006 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 21, 2006 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 18, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 17, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2005 | NWAP | NEW APPLICATION ENTERED | — |